News
TMCI
7.90
+0.38%
0.03
Weekly Report: what happened at TMCI last week (1230-0103)?
Weekly Report · 15h ago
Insiders Of Treace Medical Concepts Are Up 58% On Their US$7.31m Purchase
Simply Wall St · 3d ago
CompoSecure to spin off Resolute, EHang raises Q4 revenue view; Morning Buzz
TipRanks · 12/31/2024 17:05
Yum, Ralph Lauren upgraded: Wall Street’s top analyst calls
TipRanks · 12/31/2024 14:35
This Vertex Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Tuesday
Benzinga · 12/31/2024 14:22
Treace Medical Concepts Price Target Announced at $14.50/Share by Lake Street
Dow Jones · 12/31/2024 14:15
Lake Street Initiates Coverage On Treace Medical Concepts with Buy Rating, Announces Price Target of $14.5
Benzinga · 12/31/2024 14:05
Treace Medical initiated with a Buy at Lake Street
TipRanks · 12/31/2024 12:50
Treace announces limited market release of Percuplastry system, procedure
TipRanks · 12/30/2024 13:20
Weekly Report: what happened at TMCI last week (1223-1227)?
Weekly Report · 12/30/2024 09:00
Treace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® Procedure
Barchart · 12/30/2024 07:15
Weekly Report: what happened at TMCI last week (1216-1220)?
Weekly Report · 12/23/2024 09:01
Deep Dive Into Treace Medical Concepts Stock: Analyst Perspectives (4 Ratings)
Benzinga · 12/18/2024 20:00
Treace Medical Concepts Price Target Raised to $8.40/Share From $7.00 by Truist Securities
Dow Jones · 12/18/2024 15:45
Treace Medical Concepts Is Maintained at Hold by Truist Securities
Dow Jones · 12/18/2024 15:45
Truist Securities Maintains Hold on Treace Medical Concepts, Raises Price Target to $8.4
Benzinga · 12/18/2024 15:35
TREACE MEDICAL CONCEPTS INC <TMCI.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $8.4 FROM $7
Reuters · 12/18/2024 12:57
U.S. RESEARCH ROUNDUP-First Solar, GE Vernova, Williams-Sonoma
Reuters · 12/18/2024 06:54
Treace Medical Concepts Coverage Assumed by JP Morgan at Neutral
Dow Jones · 12/17/2024 12:37
Treace Medical Concepts Price Target Announced at $8.00/Share by JP Morgan
Dow Jones · 12/17/2024 12:37
More
Webull provides a variety of real-time TMCI stock news. You can receive the latest news about Treace Medical Concepts, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About TMCI
Treace Medical Concepts, Inc. is a medical technology company. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The Company sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.